Lucid Diagnostics Long-Term Investments 2021-2025 | LUCD

Lucid Diagnostics long-term investments from 2021 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.

Lucid Diagnostics Long-Term Investments 2021-2025 | LUCD

Lucid Diagnostics long-term investments from 2021 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$186.1B
Intuitive Surgical (ISRG)$169.7B
IDEXX Laboratories (IDXX)$51.8B
Edwards Lifesciences (EW)$47.8B
Alcon (ALC)$39.4B
IQVIA Holdings (IQV)$32.4B
DexCom (DXCM)$29.5B
Mettler-Toledo (MTD)$26.8B
STERIS (STE)$24.1B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.4B
Hologic (HOLX)$14.9B
Penumbra (PEN)$10.6B
Globus Medical (GMED)$8.3B
Sysmex ADR (SSMXY)$7.9B
Masimo (MASI)$7.6B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.5B
TransMedics (TMDX)$3.9B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3.1B
Veracyte (VCYT)$2.4B
Alphatec Holdings (ATEC)$2.4B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.8B
Integra LifeSciences Holdings (IART)$1.2B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B